{"title":"Identification of a novel coronavirus and the landscape of prevention and control of emerging infectious diseases","authors":"Wenhong Zhang","doi":"10.3760/CMA.J.ISSN.1000-6680.2020.01.002","DOIUrl":null,"url":null,"abstract":"Since December 2019, there has been widespread concern over an unexplained pneumonia epidemic in Wuhan. Less than a month later, the expert team has identified the etiology, a novel coronavirus, which has won a \"golden window\" for effectively preventing the spread of the emerging infectious diseases. The prompt response of Chinese researchers to emerging infectious diseases has been recognized and appreciated by the World Health Organization, and reflects that the substantially improved ability to identify emerging infectious diseases. However, the strength of the current infectious disease discipline in China has yet to be further strengthened to meet the needs of China's public health development and the challenges of infectious diseases. Faced with urban aging and the spread of drug-resistant bacterial infections, as well as the increase in imported diseases and the uncontrollable risks of unknown infectious diseases, the future demand for infectious disease prevention and control systems in China is diverse, open, and flexible, including but It is not limited to the prevention and control of communicable diseases, diagnosis and treatment of bacterial and fungi infections, nosocomial infection control, and the use of antibiotic-resistant antibacterial drugs. Infectious disease professionals take on important tasks and responsibilities to protect the \"Healthy China\" strategy. \n \n \nKey words: \nSARS-CoV-2 infection; New infectious diseases; Identification of virus","PeriodicalId":10127,"journal":{"name":"中华传染病杂志","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华传染病杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1000-6680.2020.01.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Since December 2019, there has been widespread concern over an unexplained pneumonia epidemic in Wuhan. Less than a month later, the expert team has identified the etiology, a novel coronavirus, which has won a "golden window" for effectively preventing the spread of the emerging infectious diseases. The prompt response of Chinese researchers to emerging infectious diseases has been recognized and appreciated by the World Health Organization, and reflects that the substantially improved ability to identify emerging infectious diseases. However, the strength of the current infectious disease discipline in China has yet to be further strengthened to meet the needs of China's public health development and the challenges of infectious diseases. Faced with urban aging and the spread of drug-resistant bacterial infections, as well as the increase in imported diseases and the uncontrollable risks of unknown infectious diseases, the future demand for infectious disease prevention and control systems in China is diverse, open, and flexible, including but It is not limited to the prevention and control of communicable diseases, diagnosis and treatment of bacterial and fungi infections, nosocomial infection control, and the use of antibiotic-resistant antibacterial drugs. Infectious disease professionals take on important tasks and responsibilities to protect the "Healthy China" strategy.
Key words:
SARS-CoV-2 infection; New infectious diseases; Identification of virus
期刊介绍:
The Chinese Journal of Infectious Diseases was founded in February 1983. It is an academic journal on infectious diseases supervised by the China Association for Science and Technology, sponsored by the Chinese Medical Association, and hosted by the Shanghai Medical Association. The journal targets infectious disease physicians as its main readers, taking into account physicians of other interdisciplinary disciplines, and timely reports on leading scientific research results and clinical diagnosis and treatment experience in the field of infectious diseases, as well as basic theoretical research that has a guiding role in the clinical practice of infectious diseases and is closely integrated with the actual clinical practice of infectious diseases. Columns include reviews (including editor-in-chief reviews), expert lectures, consensus and guidelines (including interpretations), monographs, short monographs, academic debates, epidemic news, international dynamics, case reports, reviews, lectures, meeting minutes, etc.